Related Experiment Videos
Histopathologic effects of mitomycin-C on endoscopic transnasal dacryocystorhinostomy
S H Ugurbas1, G Zilelioglu, M F Sargon
1Department of Ophthalmology, Ankara University, Faculty of Medicine, Turkey.
Background And Objectives:
The antimetabolite mitomycin-C is now being used in endoscopic transnasal dacryocystorhinostomies to prevent the closure of osteotomies.
Patients And Methods:
A 0.5-mg/ml solution of mitomycin-C was applied to the osteotomy site for 2 1/2 minutes intraoperatively. Specimens from four patients were collected during surgery and at 15 days, 1 months, 3 months, and 6 months after surgery. The specimens were examined under light and electron transmission microscopy and were compared with control specimens.
Results:
Light microscopy showed attenuated epithelium with intracytoplasmic vacuoles. Subepithelial connective tissue was looser and hypocellular. Electron microscopy confirmed these findings and demonstrated swelling of mitochondria, dilatation of endoplasmic reticulum, and chromatin-dense granules in nuclei of fibroblasts.
Conclusion:
By causing a decrease in density and cellularity of mucosa, topical use of mitomycin-C may enhance the success of surgery; however, further studies are necessary to determine the ultimate potential of this agent for this procedure.
Insights
Topical mitomycin-C (MMC) use in endoscopic dacryocystorhinostomy may improve surgical success by reducing mucosal density. Further research is needed to confirm its efficacy and potential benefits.
Area of Science:
- Ophthalmology
- Surgical Oncology
Background:
- Mitomycin-C (MMC), an antimetabolite, is utilized in endoscopic transnasal dacryocystorhinostomies.
- Its application aims to prevent the closure of osteotomies post-surgery.
Purpose of the Study:
- To evaluate the histological effects of topical mitomycin-C on osteotomy sites in endoscopic dacryocystorhinostomy.
- To assess the potential of mitomycin-C to enhance surgical outcomes by modifying mucosal tissue.
Main Methods:
- A 0.5 mg/ml mitomycin-C solution was applied to the osteotomy site for 2.5 minutes intraoperatively.
- Tissue specimens were collected from four patients at various time points (surgery, 15 days, 1, 3, and 6 months post-surgery).
- Histological analysis was performed using light and electron transmission microscopy, with comparisons to control specimens.
Main Results:
- Light microscopy revealed attenuated epithelium with intracytoplasmic vacuoles and looser, hypocellular subepithelial connective tissue.
- Electron microscopy confirmed these changes, noting mitochondrial swelling, endoplasmic reticulum dilation, and dense granules in fibroblast nuclei.
- These findings indicate significant cellular alterations in the mucosa following mitomycin-C application.
Conclusions:
- Topical mitomycin-C application may enhance dacryocystorhinostomy success by decreasing mucosal density and cellularity.
- Further investigations are required to fully ascertain the therapeutic potential of mitomycin-C in this surgical procedure.